Patient Capital Management, LLC: CVS HEALTH CORP (CVS): Quarterly 13F Position History
As of Q2 2026, Patient Capital Management, LLC reported 1,235,505 shares of CVS HEALTH CORP (CVS), worth $127.8M and representing 4.2% of its 13F equity book. Quarter-over-quarter share count change: 121,654 (-9.0%) . The position first appeared in Q3 2023 and has been disclosed across 12 13F-HR filings in Pactolio's tracked window.
- 1,235,505Shares Held (Latest Filing)
- $127.8MReported Market Value (Latest Filing)
- 4.2%Portfolio Weight (% of 13F Equity Book)
- 121,654Quarter-over-Quarter Share Change
- +$30.3MQuarter-over-Quarter Value Change
- 1,357,159Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 12 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,235,505 | 121,654 | -9.0% | $127.8M | 4.2% | $103.5 |
| Q1 2026 | 1,357,159 | +125,743 | +10.2% | $97.5M | 3.6% | $71.8 |
| Q4 2025 | 1,231,416 | 8,478 | -0.7% | $97.7M | 3.8% | $79.4 |
| Q3 2025 | 1,239,894 | 2,030 | -0.2% | $93.5M | 3.7% | $75.4 |
| Q2 2025 | 1,241,924 | 83,714 | -6.3% | $85.7M | 3.9% | $69.0 |
| Q1 2025 | 1,325,638 | +27,209 | +2.1% | $89.8M | 4.6% | $67.8 |
| Q4 2024 | 1,298,429 | +529,333 | +68.8% | $58.3M | 2.7% | $44.9 |
| Q3 2024 | 769,096 | +29,387 | +4.0% | $48.4M | 2.4% | $62.9 |
| Q2 2024 | 739,709 | +167,135 | +29.2% | $43.7M | 2.3% | $59.1 |
| Q1 2024 | 572,574 | 28,403 | -4.7% | $45.7M | 2.2% | $79.8 |
| Q4 2023 | 600,977 | 4,143 | -0.7% | $47.5M | 2.5% | $79.0 |
| Q3 2023 | 605,120 | – | – | $42.2M | 2.5% | $69.8 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Patient Capital Management, LLC first disclose a CVS position in 13F-HR filings?
Patient Capital Management, LLC first reported CVS HEALTH CORP (CVS) on its 13F-HR filing for the period ending 2023-09-30 (Q3 2023). The position has appeared on 12 reported quarters within Pactolio's tracked window.
What was Patient Capital Management, LLC's most recent quarter-over-quarter share-count change in CVS?
Between Q1 2026 and Q2 2026, Patient Capital Management, LLC reduced its CVS position by 121,654 shares (-9.0%), leaving 1,235,505 shares at a market value of $127.8M.
Does the implied price-per-share represent Patient Capital Management, LLC's cost basis in CVS?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.